
← The Studio at Kendall Square28 sep · 20 min
Valo Health experts discuss how technology, data, and biology are converging to redefine how drug discovery and development are done
Valo Health experts discuss how technology, data, and biology are converging to redefine how drug discovery and development are done
<p>CSO Karin Conde-Knape and Chief Causal AI Officer Chris Anagnostopoulos discuss the difference between data collection in clinical trials and clinical care, and why they believe our industry has been underutilizing and sometimes misusing these data sets. They discusses the latest ways of harnessing technology to find targets that have a higher probability of clinical success.</p>